Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemia

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Liu, Yan ^a,d   Huang, Congwu ^b   Ceng, Chuan ^b   Zhan, Haiyong ^b   Zheng, Dongdan ^c   Han, Weixing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SHANTOU UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d Department of Radiology   (China)

Author keywords

Hyperlipidemia; Nitric oxide; Rho kinase

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; METFORMIN; NITRIC OXIDE; PYRROLE DERIVATIVE; RHO KINASE;

ANIMAL; BIOSYNTHESIS; BLOOD; DRUG SCREENING; ENZYMOLOGY; HYPERCHOLESTEROLEMIA; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; C-REACTIVE PROTEIN; DRUG EVALUATION, PRECLINICAL; HEPTANOIC ACIDS; HYPERCHOLESTEROLEMIA; MALE; METFORMIN; NITRIC OXIDE; PYRROLES; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES;

EID: 84904078023     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-115     Document Type: Article

References (32)

1. - 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Goff DC Jr, Lloyd-Jones DM, Bennett G, O'Donnell CJ, Coady S, Robinson J, D'Agostino RB Sr, Schwartz JS, Gibbons R, Shero ST, Greenland P, Smith SC Jr, Lackland DT, Sorlie P, Levy D, Stone NJ, Wilson PW, J Am Coll Cardiol 2013 S0735-1097 13 06031 06032
2. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C, Lancet 2008 371 117 125
3. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, N Engl J Med 2005 352 1425 1435 (Pubitemid 40471450)
4. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Pruefer D, Scalia R, Lefer AM, Arterioscler Thromb Vasc Biol 1999 19 2894 2900 (Pubitemid 30029815)
5. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Veillard NR, Braunersreuther V, Arnaud C, Burger F, Pelli G, Steffens S, Mach F, Atherosclerosis 2006 188 51 58 (Pubitemid 44142533)
6. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C, Curr Pharm Des 2012 18 1519 1530
7. Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR-/-mice. Wang HW, Liu PY, Oyama N, Rikitake Y, Kitamoto S, Gitlin J, Liao JK, Boisvert WA, FASEB J 2008 22 3561 3570
8. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. Sawada N, Liao JK, Antioxid Redox Signal 2014 20 1251 1267
9. Small G proteins in the cardiovascular system: physiological and pathological aspects. Loirand G, Sauzeau V, Pacaud P, Physiol Rev 2013 93 1659 1720
10. Increased Rho kinase activity in a Taiwanese population with metabolic syndrome. Liu PY, Chen JH, Lin LJ, Liao JK, J Am Coll Cardiol 2007 49 1619 1624 (Pubitemid 46551629)
11. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. Noma K, Rikitake Y, Oyama N, Yan G, Alcaide P, Liu PY, Wang H, Ahl D, Sawada N, Okamoto R, Hiroi Y, Shimizu K, Luscinskas FW, Sun J, Liao JK, J Clin Invest 2008 118 1632 1644 (Pubitemid 351632368)
12. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK, Circulation 2009 119 131 138
13. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. Rawlings R, Nohria A, Liu PY, Donnelly J, Creager MA, Ganz P, Selwyn A, Liao JK, Am J Cardiol 2009 103 437 441
14. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Gundewar S, Calvert JW, Jha S, Toedt-Pingel I, Ji SY, Nunez D, Ramachandran A, Anaya-Cisneros M, Tian R, Lefer DJ, Circ Res 2009 104 403 411
15. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R, Lefer DJ, Diabetes 2008 57 696 705
16. Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats. Benes J, Kazdova L, Drahota Z, Houstek J, Medrikova D, Kopecky J, Kovarova N, Vrbacky M, Sedmera D, Strnad H, Kolar M, Petrak J, Benada O, Skaroupkova P, Cervenka L, Melenovsky V, Clin Sci (Lond) 2011 121 29 41
17. Atherosclerosis-an inflammatory disease. Ross R, N Engl J Med 1999 340 115 126
18. NICE guideline on lipid modification. Jaques H, Eur Heart J 2013 34 481 482
19. Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults. Lo-Ciganic WH, Boudreau RM, Gray SL, Zgibor JC, Donohue JM, Perera S, Newman AB, Simonsick EM, Bauer DC, Satterfield S, Hanlon JT, Ann Pharmacother 2013 47 984 992
20. Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia. Huang C, Ceng C, Wang C, Zhan H, Ding X, Lipids Health Dis 2014 13 67
21. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery. Shiga N, Hirano K, Hirano M, Nishimura J, Nawata H, Kanaide H, Circ Res 2005 96 1014 1021 (Pubitemid 40712802)
22. Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial. He H, Zhao Z, Chen J, Ni Y, Zhong J, Yan Z, Li Y, Liu D, Pletcher MJ, Zhu Z, J Hypertens 2012 30 1430 1439
23. Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus. Carter AM, Bennett CE, Bostock JA, Grant PJ, Diabet Med 2005 22 1282 1284 (Pubitemid 41224195)
24. RhoA and resistance artery remodeling. Loirand G, Rolli-Derkinderen M, Pacaud P, Am J Physiol Heart Circ Physiol 2005 288 1051 H1056
25. Role of nitric oxide synthases in the pathogenesis of cardiovascular disease. Tsutsui M, Shimokawa H, Otsuji Y, Yanagihara N, Nihon Yakurigaku Zasshi 2014 143 226 231
26. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Bailey CJ, Cardiovasc Drugs Ther 2008 22 215 224
27. Acute and chronic NOS inhibition enhances alpha(2)- adrenoreceptor- stimulated RhoA and Rho kinase in rat aorta. Carter RW, Begaye M, Kanagy NL, Am J Physiol Heart Circ Physiol 2002 283 1361 H1369
28. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Kataoka C, Egashira K, Inoue S, Takemoto M, Ni W, Koyanagi M, Kitamoto S, Usui M, Kaibuchi K, Shimokawa H, Takeshita A, Hypertension 2002 39 245 250 (Pubitemid 34165223)
29. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. Hirose A, Tanikawa T, Mori H, Okada Y, Tanaka Y, FEBS Lett 2010 584 61 66
30. SDF-1alpha upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects. Qiu R, Cai A, Dong Y, Zhou Y, Yu D, Huang Y, Zheng D, Rao S, Feng Y, Mai W, J Biomed Sci 2012 19 99
31. Anti-inflammatory drugs and their effects on type 2 diabetes. Deans KA, Sattar N, Diabetes Technol Ther 2006 8 18 27
32. Crucial role of rho-kinase in pressure overload-induced right ventricular hypertrophy and dysfunction in mice. Ikeda S, Satoh K, Kikuchi N, Miyata S, Suzuki K, Omura J, Shimizu T, Kobayashi K, Kobayashi K, Fukumoto Y, Sakata Y, Shimokawa H, Ikeda S, Satoh K, Kikuchi N, Miyata S, Suzuki K, Omura J, Shimizu T, Kobayashi K, Kobayashi K, Fukumoto Y, Sakata Y, Shimokawa H, Arterioscler Thromb Vasc Biol 2014 34 1260 1271